Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 2Brain Neoplasms 2Gliosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 6Yoga 2Temozolomide 2Gadolinium DTPA 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1fluorodopa F 18 1alovudine 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Mind-Body Therapies 1Methotrexate 1Meditation 1Magnetic Resonance Imaging 1Etanidazole 1Early Intervention, Educational 1DNA Methylation 1Congresses as Topic 1Chemotherapy, Adjuvant 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gliosarcoma × Perfusion Magnetic Resonance Imaging × Clear all
NCT03115333 2026-05-06

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
146 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡